Published in Neurology on March 01, 1995
Multisystem Lewy body disease and the other parkinsonian disorders. Nat Genet (2015) 1.57
Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls. Hum Mol Genet (2008) 1.44
Leucine-rich repeat kinase 2 gene-associated disease: redefining genotype-phenotype correlation. Neurodegener Dis (2010) 1.31
The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval. Am J Hum Genet (2003) 1.30
Familial parkinsonism: study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes. Parkinsonism Relat Disord (2008) 1.00
Ten years and counting: moving leucine-rich repeat kinase 2 inhibitors to the clinic. Mov Disord (2014) 0.94
Genes and parkinsonism. J Neurol Neurosurg Psychiatry (1997) 0.89
Creation of an open-access, mutation-defined fibroblast resource for neurological disease research. PLoS One (2012) 0.88
Synaptic dysfunction in genetic models of Parkinson's disease: a role for autophagy? Neurobiol Dis (2010) 0.88
Genetically engineered mouse models of Parkinson's disease. Brain Res Bull (2011) 0.86
Leucine-rich repeat kinase 2 for beginners: six key questions. Cold Spring Harb Perspect Med (2012) 0.86
The Identification of Alpha-Synuclein as the First Parkinson Disease Gene. J Parkinsons Dis (2017) 0.75
Cancer in Parkinson's disease. Parkinsonism Relat Disord (2016) 0.75
Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol (1997) 6.02
Multiple receptors for dopamine. Nature (1979) 5.51
Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol (2003) 5.17
Double-blind study of botulinum toxin in spasmodic torticollis. Lancet (1986) 4.54
Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology (2002) 4.50
Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain (2007) 3.82
Levodopa failure in chronic manganism. Neurology (1994) 3.80
Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology (2006) 3.60
Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology (2004) 3.41
Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications. Neurology (2011) 3.30
Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science (2001) 3.18
Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain (2008) 3.05
Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology (1999) 2.81
Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol (1993) 2.75
Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset. Neurology (2008) 2.73
L-dopa in postencephalitic parkinsonism. Lancet (1969) 2.72
MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study. Neurology (2008) 2.69
A scoring error in the Mini-Mental State test. Can J Psychiatry (1993) 2.69
Gastrointestinal dysfunction in Parkinson's disease: frequency and pathophysiology. Neurology (1992) 2.57
Parkinson's disease in 65 pairs of twins and in a set of quadruplets. Neurology (1983) 2.47
Progressive aphasia secondary to Alzheimer disease vs FTLD pathology. Neurology (2008) 2.45
Bromocriptine in Parkinsonism. Br Med J (1974) 2.44
Intra-arterial thrombolysis in acute basilar artery thromboembolism: the initial Mayo Clinic experience. Mayo Clin Proc (1997) 2.34
Aetiology of Parkinson's disease. Lancet (1984) 2.32
Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover. Ann Neurol (2001) 2.31
Remote cerebellar hemorrhage after supratentorial surgery. Neurosurgery (2001) 2.30
Synthesis and biological evaluation of N-(7-indazolyl)benzenesulfonamide derivatives as potent cell cycle inhibitors. Bioorg Med Chem (2005) 2.29
Frontotemporal brain sagging syndrome: an SIH-like presentation mimicking FTD. Neurology (2011) 2.27
Prognostic value of myoclonus status in comatose survivors of cardiac arrest. Ann Neurol (1994) 2.25
Treatment of spasticity with botulinum toxin: a double-blind study. Ann Neurol (1990) 2.18
Intraosseous infusion: an alternative route of pediatric intravascular access. Ann Emerg Med (1985) 2.14
Hemangiopericytoma of the central nervous system: a review of 94 cases. Hum Pathol (1991) 2.12
Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. N Engl J Med (1985) 2.09
Vocal cord paralysis in the Shy-Drager syndrome. J Neurol Neurosurg Psychiatry (1979) 2.04
Predictors of neuropsychological outcome in patients following microelectrode-guided pallidotomy for Parkinson's disease. J Neurosurg (2000) 2.02
Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype. Neurology (2008) 2.01
Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord (2001) 2.00
Manganese neurotoxicity: a review of clinical features, imaging and pathology. Neurotoxicology (1999) 1.97
Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology (2003) 1.97
Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione. J Neurosci (1999) 1.96
Rapidly progressive aphasic dementia and motor neuron disease. Ann Neurol (1993) 1.93
Electrically silent cotransport on Na+, K+ and Cl- in Ehrlich cells. Biochim Biophys Acta (1980) 1.92
Reaction time in Parkinson's disease. Brain (1981) 1.92
Magnetic resonance imaging-based volume studies in temporal lobe epilepsy: pathological correlations. Ann Neurol (1991) 1.89
Genetic heterogeneity in familial idiopathic basal ganglia calcification (Fahr disease). Neurology (2004) 1.87
X-linked scapuloperoneal syndrome. J Neurol Neurosurg Psychiatry (1972) 1.87
Autosomal dominant parkinsonism associated with variable synuclein and tau pathology. Neurology (2004) 1.86
L-dopa in idiopathic parkinsonism. Lancet (1969) 1.86
A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat Genet (1998) 1.84
Hypotension caused by L-dopa. Br Med J (1970) 1.81
Hereditary adult-onset Alexander's disease with palatal myoclonus, spastic paraparesis, and cerebellar ataxia. Neurology (1995) 1.79
Positron emission tomography in manganese intoxication. Ann Neurol (1989) 1.78
Sporadic adult-onset leukoencephalopathy with neuroaxonal spheroids mimicking cerebral MS. Neurology (2008) 1.78
Depletion of catecholaminergic neurons of the rostral ventrolateral medulla in multiple systems atrophy with autonomic failure. Ann Neurol (1998) 1.76
Sudden death from aneurysmal subarachnoid hemorrhage. Neurology (1995) 1.76
Wegener's granulomatosis associated with vasculitis of the temporal artery: report of five cases. Mayo Clin Proc (1993) 1.75
Imaging correlates of pathology in corticobasal syndrome. Neurology (2010) 1.71
The antiparkinson efficacy of deprenyl derives from transient improvement that is likely to be symptomatic. Ann Neurol (1992) 1.67
The Mini-Mental State Examination in general medical practice: clinical utility and acceptance. Mayo Clin Proc (1996) 1.67
Alzheimer's disease, Parkinson's disease, and motoneurone disease: abiotrophic interaction between ageing and environment? Lancet (1986) 1.65
In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease. Ann Neurol (2000) 1.65
A Greek-American kindred with autosomal dominant, levodopa-responsive parkinsonism and anticipation. Ann Neurol (1995) 1.64
Cardiovascular reflexes in Parkinsonism. Clin Sci (1971) 1.62
Idiopathic Parkinsonism treated with an extracerebral decarboxylase inhibitor in combination with levodopa. Br Med J (1971) 1.60
Manganese intoxication in the rhesus monkey: a clinical, imaging, pathologic, and biochemical study. Neurology (1996) 1.60
Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies. Neurology (2011) 1.59
CFS hydroxylase cofactor levels in some neurological diseases. J Neurol Neurosurg Psychiatry (1980) 1.59
Meningeal biopsy in intracranial hypotension: meningeal enhancement on MRI. Neurology (1995) 1.59
Selegiline in Parkinson's disease. BMJ (1995) 1.58
Mesial temporal sclerosis: diagnosis with fluid-attenuated inversion-recovery versus spin-echo MR imaging. Radiology (1996) 1.55
The trends in incidence of primary brain tumors in the population of Rochester, Minnesota. Ann Neurol (1995) 1.54
Acute deterioration from thrombosis and rerupture of a giant intracranial aneurysm. Neurology (1999) 1.51
Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism. J Neurol Neurosurg Psychiatry (2000) 1.49
REM sleep behavior disorder and degenerative dementia: an association likely reflecting Lewy body disease. Neurology (1998) 1.49
Brain death with prolonged somatic survival. N Engl J Med (1982) 1.48
Motor nerve conduction velocity in peroneal muscular atrophy: evidence for genetic heterogeneity. J Neurol Neurosurg Psychiatry (1974) 1.47
Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. J Neurol Neurosurg Psychiatry (1995) 1.47
Variation in GIGYF2 is not associated with Parkinson disease. Neurology (2009) 1.47
The relationship between cerebral blood flow and transcranial Doppler blood flow velocity during hypothermic cardiopulmonary bypass in adults. Anesth Analg (1996) 1.46
Positron emission tomography suggests that the rate of progression of idiopathic parkinsonism is slow. Ann Neurol (1991) 1.46
Clinical and pathologic features of families with LRRK2-associated Parkinson's disease. J Neural Transm Suppl (2006) 1.46
Angiographically occult vascular malformations: a correlative study of features on magnetic resonance imaging and histological examination. Neurosurgery (1994) 1.45
Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion? Ann Neurol (1997) 1.45
Gastrointestinal symptoms in Parkinson's disease. Mov Disord (1991) 1.44
Familial intracranial aneurysms: an autopsy study. Neurosurgery (1997) 1.43
Charles Bonnet syndrome. J Am Geriatr Soc (1996) 1.43
The reproducibility of striatal uptake data obtained with positron emission tomography and fluorine-18-L-6-fluorodopa tracer in non-human primates. J Nucl Med (1991) 1.42
Action of dopamine on the human iris. Br Med J (1969) 1.42
Novel THAP1 sequence variants in primary dystonia. Neurology (2010) 1.42
Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia. Neurocase (2005) 1.41
Essential tremor: predictors of disease progression in a clinical cohort. J Neurol Neurosurg Psychiatry (2006) 1.41
Tropicamide eyedrops cannot be used for reliable diagnosis of Alzheimer's disease. Mayo Clin Proc (1997) 1.40
Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease. Neurology (2008) 1.39
Hereditary form of parkinsonism--dementia. Ann Neurol (1998) 1.39
1995-1996 SAEM emergency medicine faculty salary/benefits survey. Acad Emerg Med (1998) 1.38
Arterial fibromuscular dysplasia associated with severe alpha 1-antitrypsin deficiency. Mayo Clin Proc (1994) 1.38